For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

As of 2:29:13 PM EST. Market Open.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Regeneron and Illumina have joined a major investment ... will use leftover biospecimens from routine lab tests to sequence up to ten million exomes – all of the exons in a genome that code ...

Aneuploidy is frequent in cancer, but in vitro it triggers multiple cellular stresses and often delays proliferation. Through ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes. A study involving 14% of the people in Greenland ...